[(2R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘧啶核苷酸
• 英文名称: [(2R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate
• 化学式: C₉H₁₅N₃O₁₁P₂
• 分子量: 403.18
• InChiKey: ZWIADYZPOWUWEW-AYZDMWBASA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -4.5
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  222
• 氢给体数：
  6
• 氢受体数：
  11

文献信息

• Nucleotide mimics and their prodrugs
  申请人：——

  公开号：US20040059104A1

  公开（公告）日：2004-03-25

  The present invention relates to nucleoside diphosphate mimics and nucleoside triphosphate mimics, which contain diphosphate or triphosphate moiety mimics and optionally sugar-modifications and/or base-modifications. The nucleotide mimics of the present invention, in a form of a pharmaceutically acceptable salt, a pharmaceutically acceptable prodrug, or a pharmaceutical formulation, are useful as antiviral, antimicrobial, and anticancer agents. The present invention provides a method for the treatment of viral infections, microbial infections, and proliferative disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of the present invention optionally in combination with other pharmaceutically active agents.

  本发明涉及核苷二磷酸模拟物和核苷三磷酸模拟物，其中包含二磷酸或三磷酸基团模拟物，以及可选的糖修饰和/或碱基修饰。本发明的核苷酸模拟物，以药学上可接受的盐、药学上可接受的前药或药物配方的形式，可用作抗病毒、抗微生物和抗癌剂。本发明提供了一种治疗病毒感染、微生物感染和增生性疾病的方法。本发明还涉及包含本发明化合物的药物组合物，可选地与其他药理活性剂结合。
• MODIFIED NUCLEOTIDES METHODS AND KITS
  申请人：Etienne Christopher L.

  公开号：US20120252691A1

  公开（公告）日：2012-10-04

  Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.

  修饰核苷酸及其修饰方法，使用含有生物素等标记的基团修饰核苷酸，使其能够被检测，从而得到修饰后的核苷酸，并且使用修饰后的核苷酸进行定量和定性分析的方法。
• Modified Nucleotides Methods and Kits
  申请人：Pierce Biotechnology, Inc.

  公开号：EP2669291A1

  公开（公告）日：2013-12-04

  Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays. The modified nucleotide compound having the structure (I): (P1)(P2)-Nucleoside(Nus)-Connecting Group (Alk)-Linking Group (Lnk)-Observable Label (Obs) (I).

  修改核苷酸，以及使用可以检测它们并导致修改核苷酸的基团或标签（例如生物素）来修改核苷酸的方法，以及在定量和定性分析中使用修改核苷酸的方法。具有结构（I）的修改核苷酸化合物：（P1）（P2）-核苷（Nus）-连接基团（Alk）-连接基团（Lnk）-可观察标签（Obs）（I）。
• Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
  申请人：——

  公开号：US20020068331A1

  公开（公告）日：2002-06-06

  This invention contemplates improved methods of enzymatic production of carbohydrates especially fucosylated carbohydrates. Improved syntheses of glycosyl 1- or 2-phosphates using both chemical and enzymatic means are also contemplated. The phosphorylated glycosides are then used to produce sugar nucleotides that are in turn used as donor sugars for glycosylation of acceptor carbohydrates. Especially preferred herein is the use of a disclosed method for fucosylation.

  本发明涉及改进的酶制糖类特别是富含岩藻糖的生产方法。同时，本发明还考虑利用化学和酶法改进糖基1-或2-磷酸的合成方法。然后，将磷酸化糖苷用于生产糖核苷，进而用作供体糖，用于受体糖的糖基化。在此，特别偏爱使用揭示的富含岩藻糖的方法。
• MODIFIED NUCLEOTIDES
  申请人：Opperman Kay

  公开号：US20110262917A1

  公开（公告）日：2011-10-27

  Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.

  修改核苷酸，以及使用分子或标记（如生物素）修饰核苷酸的方法，使其能够被检测并产生修改的核苷酸，以及在定量和定性分析中使用修改的核苷酸的方法。